Irwin Federman, 10% Owner at OncoMed Pharmaceuticals Inc (OMED), bought 1,187,204 shares at $17.00 ($2.7M) on 2013-07-23, disclosed to the SEC on 2013-07-23.
Open-market purchase of $2.7M OMED by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,028,381 | $0 | 0.0% |
| 2 | $17.00 | 727 | $12K | 0.5% |
| 3 | $17.00 | 1,434 | $24K | 0.9% |
| 4 | $17.00 | 1,498 | $25K | 0.9% |
| 5 | $17.00 | 155,164 | $2.6M | 97.7% |
| Total | $2.27 avg | 1,187,204 |
| $2.7M |
| 100% |
| Filing → |
| ONTF | SELL | 2021-08-19 | $632K | — | Filing → |
| ONTF | SELL | 2021-08-13 | $338K | — | Filing → |
| IMI | BUY | 2016-08-15 | $224K | — | Filing → |